• 1
    Stanley JR. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest 1989; 83:14438.
  • 2
    Hertl M. Humoral and cellular autoimmunity in autoimmune bullous skin disorders. Int Arch Allergy Immunol 2000; 122:91100.
  • 3
    Yancey KB. The pathophysiology of autoimmune blistering diseases. J Clin Invest 2005; 115:8258.
  • 4
    Nishifuji K, Amagai M, Kuwana M, Iwasaki T, Nishikawa T. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production. J Invest Dermatol 2000; 114:8894.
  • 5
    Kaneko F, Minagawa T, Takiguchi Y, Suzuki M, Itoh N. Role of cell-mediated immune reaction in blister formation of bullous pemphigoid. Dermatology 1992; 184:349.
  • 6
    Hertl M, Eming R, Veldman C. T cell control in autoimmune bullous skin disorders. J Clin Invest 2006; 116:115966.
  • 7
    Wojnarowska F, Venning VA, Burge SM. Immunobullous diseases. In: BurnsT, BreathnachS, CoxN, GriffithsC, eds. Rook's textbook of dermatology. Oxford: Blackwell Science Ltd, 2004:41·141·59.
  • 8
    Levi M, Van Der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005; 15:2549.
  • 9
    So AK, Varisco PA, Kemkes-Matthes B et al. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost 2003; 1:251015.
  • 10
    Ingegnoli F, Fantini F, Favalli EG et al. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade. J Autoimmun 2008; 31:1759.
  • 11
    Kume K, Yamasaki M, Tashiro M, Yoshikawa I, Otsuki M. Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis. Intern Med 2007; 46:13239.
  • 12
    Liaw PC, Esmon CT, Kahnamoui K et al. Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood 2004; 104:395864.
  • 13
    Wiersinga WJ, Meijers JC, Levi M et al. Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis. J Thromb Haemost 2008; 6:329.
  • 14
    Bauer KA, Weitz JI. Laboratory markers of coagulation and fibrinolysis. In: ColmanRW, HirshJ, MarderVJ, ClowesAW, GeorgeJN, eds. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia, PA: JB Lippincott, 2001:111329.
  • 15
    Marzano AV, Tedeschi A, Fanoni D et al. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications. Br J Dermatol 2008; 160:26672 [Epub ahead of print.
  • 16
    Borrego L, Maynard B, Peterson EA et al. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am J Pathol 1996; 148:897909.
  • 17
    Frezzolini A, Cianchini G, Ruffelli M, Cadoni S, Puddu P, De Pita O. Interleukin-16 expression and release in bullous pemphigoid. Clin Exp Immunol 2004; 137:595600.
  • 18
    Budinger L, Borradori L, Yee C et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 1998; 102:20829.
  • 19
    Frezzolini A, Teofoli P, Cianchini G et al. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid. Eur J Dermatol 2002; 12:2731.
  • 20
    Hertl M, Amagai M, Sundaram H, Stanley J, Ishii K, Katz SI. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. J Invest Dermatol 1998; 110:626.
  • 21
    Caproni M, Giomi B, Cardinali C et al. Further support for a role for Th2-like cytokines in blister formation of pemphigus. Clin Immunol 2001; 98:26471.
  • 22
    Rico MJ, Benning C, Weingart ES, Streilein RD, Hall RP III. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris. Br J Dermatol 1999; 140:107986.
  • 23
    Moosbauer C, Morgenstern E, Cuvelier SL et al. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 2007; 109:9951002.
  • 24
    Garcia JG, Siflinger-Birnboim A, Bizios R, Del Vecchio PJ, Fenton JW II, Malik AB. Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol 1986; 128:96104.
  • 25
    DeMichele MA, Moon DG, Fenton JW II, Minnear FL. Thrombin's enzymatic activity increases permeability of endothelial cell monolayers. J Appl Physiol 1990; 69:1599606.
  • 26
    Chu AJ. Tissue factor mediates inflammation. Arch Biochem Biophys 2005; 440:12332.
  • 27
    Rock B, Labib RS, Diaz LA. Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice. J Clin Invest 1990; 57:2969.
  • 28
    Sitaru C, Schmidt E, Petermann S, Munteanu LS, Bröcker EB, Zillikens D. Autoantibodies to bullous pemphigoid antigen 180 induce dermal–epidermal separation in cryosections of human skin. J Invest Dermatol 2002; 118:66471.
  • 29
    Liu Z, Giudice GJ, Swartz SJ et al. The role of complement in experimental bullous pemphigoid. J Clin Invest 1995; 95:153944.
  • 30
    Rosendaal FR, Van Hylckama Vlieg A, Doggen CJM. Venous thrombosis in the elderly. J Thromb Haemost 2007; 5 (Suppl. 1):31017.
  • 31
    Garcia G, Achouh L, Cobarzan D, Fichet D, Humbert M. Severe venous thromboembolic disease in Churg–Strauss syndrome. Allergy 2005; 60:40910.
  • 32
    Allenbach Y, Seror R, Pagnoux C, Teixeira L, Guilpain P, Guillevin L. High frequency of venous thromboembolic events in Churg–Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann Rheum Dis 2009; 68:5647.
  • 33
    Ogbogu PU, Rosing DR, Horne MK III. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007; 27:45775.